Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Gemigliptin 50mg qd Added in Patients With Type 2 Diabetes Inadequately Controlled on Glimepiride and Metformin

NCT01990469 is registered in ClinicalTrials.gov with LG Life Sciences as lead sponsor.

NCT NCT01990469
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01990469 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Gemigliptin 50mg qd Added in Patients With Type 2 Diabetes Inadequately Controlled on Glimepiride and Metformin
Lead sponsor
LG Life Sciences
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2014
Completion date
April 30, 2015
Enrollment
219 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

t2dm